Post by
clutchbeyers on Jan 26, 2021 9:08am
Happy Tuesday My Sernova Longs!
Which of the 2 immune protection technology investments of AgeX Theraputics and Converge Biotech are you most excited about? Do you think they look to incorporate both into the cell pouch? Has anyone dug deep into those tracks?
So pumped for them to fill in this 3rd pillar and get to that human trial.
Comment by
BioTeck on Jan 26, 2021 9:30am
They didn't pay anything for the age x license as far as I know. I think the conformal coating will be the winner. There is lots of documentation on this, you just have to know what you're reading and have a subscription to view medical journals.
Comment by
clutchbeyers on Jan 26, 2021 9:33am
Thank you. Do you have some links to that conformal coating? I wasn't able to dig up much. Do you think they will just use the same 7 voluneteers from the saftey and efficacy portion to trial the immune protection? Or will that require a new batch of human voluneteers?
Comment by
BioTeck on Jan 26, 2021 9:38am
I did months ago via a subscription. Listen I'm not here to convince anyone to buy to sell this stock. I've always listed what I've done and will continue to do so. The averaging up in the 1.55 to 1.65 range seemed to be the right move. Let's see how this week plays out.
Comment by
clutchbeyers on Jan 26, 2021 10:05am
I bought and held for the last 10 months, no plans on selling. I am looking to dig deeper into the immune protection pillar that is the missing link.